SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Clinical trials for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug SLV-154 enters human trials for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug called SLV-154 in about 70 adults with advanced solid tumors that have spread. The main goal is to find the safest dose and check for side effects. Participants have cancers like head and neck, lung, breast, or ovarian cancer that haven't r…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated May 26, 2026 03:28 UTC
-
New trial tests if adding chemo to radiation boosts survival in head and neck cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding chemotherapy (cisplatin) to standard radiation therapy after surgery helps people with intermediate-risk head and neck squamous cell carcinoma live longer without the cancer returning. About 386 participants who have had surgery and show ce…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New radiation method aims to save cancer Patients' saliva
Symptom relief Recruiting nowThis study compares standard radiation therapy with a newer, daily adaptive technique to see if it can better protect the saliva glands in people with head and neck cancer. About 50 participants will be randomly assigned to one of the two treatments. The goal is to reduce dry mou…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 26, 2026 03:16 UTC
-
Sound waves zapped into brain to kill cancer pain
Symptom relief Recruiting nowThis early-stage study tests whether a precise ultrasound beam aimed at a pain center in the brain can safely reduce severe, opioid-resistant pain in people with head, neck, or brachial cancer. About 20 adults aged 18–85 will receive the one-time procedure. The goal is to see if …
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC